Eberhard Lurz1,2, Eliane Aeschbacher1,3, Nicholas Carman2, Susanne Schibli1, Christiane Sokollik1, Giacomo D Simonetti4,5. 1. Division of Pediatric Gastroenterology, Hepatology and Nutrition, University Children's Hospital, Inselspital, University of Bern, Bern, Switzerland. 2. Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Hospital for Sick Children, Toronto, ON, Canada. 3. Division of Pediatric Nephrology, University Children's Hospital, Inselspital, University of Bern, Bern, Switzerland. 4. Division of Pediatric Nephrology, University Children's Hospital, Inselspital, University of Bern, Bern, Switzerland. giacomo.simonetti@eoc.ch. 5. Pediatric Department of Southern Switzerland, 6500, Bellinzona, Switzerland. giacomo.simonetti@eoc.ch.
Abstract
In adults with inflammatory bowel disease (IBD), the incidence of cardiovascular events is increased, leading to long-term morbidity. Arterial stiffness (AS) measured by pulse wave velocity (PWV) is a validated early precursor of cardiovascular disease (CVD), and measurement of PWV was shown to be a feasible test in children. The aim of this study was to assess AS in children with IBD. In this prospective study, we determined PWV between the carotid and femoral artery (PWVcf) in 25 children and adolescents with IBD (11 females, median age 14.1 years, median disease duration 2.8 years). The majority (68%) of the subjects were in clinical remission, and 48% received anti-tumor necrosis factor alpha (TNFα) treatment. AS was not increased in this cohort of children and adolescents with IBD, who did not have signs of cardiovascular disease, such as arterial hypertension. CONCLUSION: PWV seems to be normal in children with IBD in remission or with mild disease activity. Larger studies should assess its potential role as a valid and non-invasive follow-up marker in children with IBD, to avoid cardiovascular complications. What is Known : • Inflammatory bowel disease (IBD) is a risk factor of cardiovascular disease (CVD). • Pulse wave velocity (PWV) measurement is the current gold standard to assess arterial stiffness (AS), which is an early predictor of CVD. What is New: • This is the first study using PWV measurements to determine AS in children with IBD. • In children with IBD in remission or only mild disease activity AS is not increased.
In adults with inflammatory bowel disease (IBD), the incidence of cardiovascular events is increased, leading to long-term morbidity. Arterial stiffness (AS) measured by pulse wave velocity (PWV) is a validated early precursor of cardiovascular disease (CVD), and measurement of PWV was shown to be a feasible test in children. The aim of this study was to assess AS in children with IBD. In this prospective study, we determined PWV between the carotid and femoral artery (PWVcf) in 25 children and adolescents with IBD (11 females, median age 14.1 years, median disease duration 2.8 years). The majority (68%) of the subjects were in clinical remission, and 48% received anti-tumornecrosis factor alpha (TNFα) treatment. AS was not increased in this cohort of children and adolescents with IBD, who did not have signs of cardiovascular disease, such as arterial hypertension. CONCLUSION: PWV seems to be normal in children with IBD in remission or with mild disease activity. Larger studies should assess its potential role as a valid and non-invasive follow-up marker in children with IBD, to avoid cardiovascular complications. What is Known : • Inflammatory bowel disease (IBD) is a risk factor of cardiovascular disease (CVD). • Pulse wave velocity (PWV) measurement is the current gold standard to assess arterial stiffness (AS), which is an early predictor of CVD. What is New: • This is the first study using PWV measurements to determine AS in children with IBD. • In children with IBD in remission or only mild disease activity AS is not increased.
Authors: Andres J Yarur; Amar R Deshpande; David M Pechman; Leonardo Tamariz; Maria T Abreu; Daniel A Sussman Journal: Am J Gastroenterol Date: 2011-03-08 Impact factor: 10.864
Authors: Michael D Kappelman; Erzsebet Horvath-Puho; Robert S Sandler; David T Rubin; Thomas A Ullman; Lars Pedersen; John A Baron; Henrik T Sørensen Journal: Gut Date: 2011-02-21 Impact factor: 23.059
Authors: Maaike M Vanderschuren; Cuno Spm Uiterwaal; Cornelis K van der Ent; Jacobien B Eising Journal: Eur J Prev Cardiol Date: 2017-07-21 Impact factor: 7.804